156 related articles for article (PubMed ID: 25752984)
1. Design and synthesis of a novel series of [1-(4-hydroxy-benzyl)-1H-indol-5-yloxy]-acetic acid compounds as potent, selective, thyroid hormone receptor β agonists.
Burkholder TP; Cunningham BE; Clayton JR; Lander PA; Brown ML; Doti RA; Durst GL; Montrose-Rafizadeh C; King C; Osborne HE; Amos RM; Zink RW; Stramm LE; Burris TP; Cardona G; Konkol DL; Reidy C; Christe ME; Genin MJ
Bioorg Med Chem Lett; 2015 Apr; 25(7):1377-80. PubMed ID: 25752984
[TBL] [Abstract][Full Text] [Related]
2. Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1.
Ye L; Li YL; Mellström K; Mellin C; Bladh LG; Koehler K; Garg N; Garcia Collazo AM; Litten C; Husman B; Persson K; Ljunggren J; Grover G; Sleph PG; George R; Malm J
J Med Chem; 2003 Apr; 46(9):1580-8. PubMed ID: 12699376
[TBL] [Abstract][Full Text] [Related]
3. In vivo evaluation of 1-benzyl-4-aminoindole-based thyroid hormone receptor β agonists: importance of liver selectivity in drug discovery.
Takahashi N; Asano Y; Maeda K; Watanabe N
Biol Pharm Bull; 2014; 37(7):1103-8. PubMed ID: 24989002
[TBL] [Abstract][Full Text] [Related]
4. Thyroid receptor ligands. Part 5: novel bicyclic agonist ligands selective for the thyroid hormone receptor beta.
Garcia Collazo AM; Koehler KF; Garg N; Färnegårdh M; Husman B; Ye L; Ljunggren J; Mellström K; Sandberg J; Grynfarb M; Ahola H; Malm J
Bioorg Med Chem Lett; 2006 Mar; 16(5):1240-4. PubMed ID: 16338239
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and structure-activity relationship (SAR) of N-[7-(4-hydroxyphenoxy)-6-methylindan-4-yl]malonamic acids as thyroid hormone receptor β (TRβ) selective agonists.
Shiohara H; Nakamura T; Kikuchi N; Ozawa T; Matsuzawa A; Nagano R; Ohnota H; Miyamoto T; Ichikawa K; Hashizume K
Bioorg Med Chem; 2013 Feb; 21(3):592-607. PubMed ID: 23276448
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a novel and potent human and rat beta3-adrenergic receptor agonist, [3-[(2R)-[[(2R)-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1H-indol-7-yloxy]acetic acid.
Harada H; Hirokawa Y; Suzuki K; Hiyama Y; Oue M; Kawashima H; Kato H; Yoshida N; Furutani Y; Kato S
Chem Pharm Bull (Tokyo); 2005 Feb; 53(2):184-98. PubMed ID: 15684518
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and pharmacological characterization of 1-benzyl-4-aminoindole-based thyroid hormone receptor β agonists.
Takahashi N; Maeda K; Asano Y; Watanabe N
Bioorg Med Chem; 2014 Jan; 22(1):488-98. PubMed ID: 24290064
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel indane derivatives as liver-selective thyroid hormone receptor β (TRβ) agonists for the treatment of dyslipidemia.
Shiohara H; Nakamura T; Kikuchi N; Ozawa T; Nagano R; Matsuzawa A; Ohnota H; Miyamoto T; Ichikawa K; Hashizume K
Bioorg Med Chem; 2012 Jun; 20(11):3622-34. PubMed ID: 22542282
[TBL] [Abstract][Full Text] [Related]
9. Complementary asymmetric routes to (R)-2-(7-hydroxy-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-yl)acetate.
Schrader TO; Johnson BR; Lopez L; Kasem M; Gharbaoui T; Sengupta D; Buzard D; Basmadjian C; Jones RM
Org Lett; 2012 Dec; 14(24):6306-9. PubMed ID: 23210718
[TBL] [Abstract][Full Text] [Related]
10. 3D-QSAR and molecular docking studies of selective agonists for the thyroid hormone receptor beta.
Du J; Qin J; Liu H; Yao X
J Mol Graph Model; 2008 Sep; 27(2):95-104. PubMed ID: 18436460
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel short chain 4-substituted indoles as potent alphavbeta3 antagonist using structure-based drug design.
Raboisson P; Desjarlais RL; Reed R; Lattanze J; Chaikin M; Manthey CL; Tomczuk BE; Marugán JJ
Eur J Med Chem; 2007 Mar; 42(3):334-43. PubMed ID: 17184884
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the development of agonists selective for beta1-type thyroid hormone receptor.
Malm J; Grover GJ; Färnegårdh M
Mini Rev Med Chem; 2007 Jan; 7(1):79-86. PubMed ID: 17266640
[TBL] [Abstract][Full Text] [Related]
13. Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index.
Erion MD; Cable EE; Ito BR; Jiang H; Fujitaki JM; Finn PD; Zhang BH; Hou J; Boyer SH; van Poelje PD; Linemeyer DL
Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15490-5. PubMed ID: 17878314
[TBL] [Abstract][Full Text] [Related]
14. Sobetirome: a case history of bench-to-clinic drug discovery and development.
Scanlan TS
Heart Fail Rev; 2010 Mar; 15(2):177-82. PubMed ID: 19002578
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of alkoxyindolyl-3-acetic acid analogs as peroxisome proliferator-activated receptor-γ/δ agonists.
Gim HJ; Li H; Lee E; Ryu JH; Jeon R
Bioorg Med Chem Lett; 2013 Jan; 23(2):513-7. PubMed ID: 23265886
[TBL] [Abstract][Full Text] [Related]
16. In vivo activity of the thyroid hormone receptor beta- and α-selective agonists GC-24 and CO23 on rat liver, heart, and brain.
Grijota-Martínez C; Samarut E; Scanlan TS; Morte B; Bernal J
Endocrinology; 2011 Mar; 152(3):1136-42. PubMed ID: 21239431
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activities of novel indole derivatives as potent and selective PPARgamma modulators.
Lamotte Y; Martres P; Faucher N; Laroze A; Grillot D; Ancellin N; Saintillan Y; Beneton V; Gampe RT
Bioorg Med Chem Lett; 2010 Feb; 20(4):1399-404. PubMed ID: 20079636
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of calindol derivatives as potent and selective calcium sensing receptor agonists.
Kiefer L; Beaumard F; Gorojankina T; Faure H; Ruat M; Dodd RH
Bioorg Med Chem; 2016 Feb; 24(4):554-69. PubMed ID: 26752095
[TBL] [Abstract][Full Text] [Related]
19. Thyroid receptor ligands. Part 4: 4'-amido bioisosteric ligands selective for the thyroid hormone receptor beta.
Li YL; Litten C; Koehler KF; Mellström K; Garg N; Garcia Collazo AM; Färnegård M; Grynfarb M; Husman B; Sandberg J; Malm J
Bioorg Med Chem Lett; 2006 Feb; 16(4):884-6. PubMed ID: 16303304
[TBL] [Abstract][Full Text] [Related]
20. Cardiac specific effects of thyroid hormone analogues.
Danzi S; Klein I
Horm Metab Res; 2011 Oct; 43(11):737-42. PubMed ID: 22009366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
